Track the CStone Pharmaceuticals - B share price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, CStone Pharmaceuticals - B has logged 24 insider filings. Market capitalisation: €9.3bn. The latest transaction was filed on 10 September 2026 (Other). Among the most active insiders: Yang Jianxin. All data is accessible without an account.
24
Insider Decl.
n/a
Thresholds
€1m
14 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CStone Pharmaceuticals - B Strong Buy (bullish), based on 4 analysts. Average price target: HK$14.34.
24Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,696 of 29,064 companies
19.8
score / 100
Value
25
Quality
15
FCF yld-3.5%
Earn yld-4.7%
EV/EBITDA·
ROE-52%
Gross mgn19%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CStone Pharmaceuticals es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para el cáncer. Cotiza en la Bolsa de Hong Kong bajo el símbolo XHKG.